Medpace Holdings (MEDP) Accumulated Expenses (2015 - 2026)

Medpace Holdings has reported Accumulated Expenses for 12 years, with the latest figure at $406.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 41.93% year-over-year to $406.1 million; the trailing twelve-month figure through Mar 2026 stood at $406.1 million (up 41.93% YoY), and the FY2025 full-year result was $408.4 million, up 32.67% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $406.1 million, down from $408.4 million in the prior quarter.
• The five-year high for Accumulated Expenses was $408.4 million in Q4 2025, with the low at $44.7 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $263.2 million across 5 years, with a median of $286.1 million in 2025.
• Annual changes were most pronounced in 2023 — Accumulated Expenses surged 350.51% — and 2024, when it gained 5.07%.
• Medpace Holdings' Accumulated Expenses stood at $210.1 million in 2022, then soared by 39.42% to $293.0 million in 2023, then increased by 5.07% to $307.8 million in 2024, then surged by 32.67% to $408.4 million in 2025, then declined by 0.57% to $406.1 million in 2026.
• The last three Accumulated Expenses figures came in at $406.1 million (Q1 2026), $408.4 million (Q4 2025), and $368.7 million (Q3 2025), per Business Quant data.